Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients

Summary

Rosuvastatin is a drug used to lower cholesterol, which also has other cardiovascular benefits. The goal of this project is to determine if rosuvastatin is effective at slowing the development of heart disease in people with HIV. We expect that after 2 years of treatment people treated with rosuvastatin will show significantly better results than people treated with a placebo.

Timeline

Start

2008-04

Primary completion

2012-12

Completion

2013-03

Outcome

Outcome not reported

Stopped (Business): “Sponsor has withdrawn the funding”

Drugs

Indications